Horizon Therapeutics Effectively Engages Patient Organizations to Improve Development of First Approved Medication for Thyroid Eye Disease Posted on June 10, 2021June 10, 2021 by Hannah Faulkner Horizon Therapeutics Effectively Engages Patient Organizations to Improve Development of First Approved Medication for Thyroid Eye Disease